Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Interventions Against Stargardt Macular Dystrophy: DHA Supplementation in Patients With STGD3

NCT00420602 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00420602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00420602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Interventions Against Stargardt Macular Dystrophy: DHA Supplementation in Patients With STGD3
Lead sponsor
University of Utah
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2007
Completion date
December 27, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dominantly inherited stargardt's disease (stgd3)